Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02205268 : Near Infrared Spectroscopy Neurofeedback Training for ADHD
PhaseN/A
AgesMin: 7 Years Max: 17 Years
Eligibility
Inclusion Criteria:

- Patients diagnosed with ADHD aged 7 to 17 years

- Patient and legal guardian able to communicate in English

- Patient has been living with parent/guardian for at least six months

- Patient attending school for at least 2 days / week

- ADHD as primary disorder with symptoms present for at least 9 months

- Participants on medication treatment for ADHD must have been on a stable dose for 3
months prior to commencement of the treatment

Exclusion Criteria:

- Significant visual or hearing impairment that would preclude use of NIRS-
neurofeedback

- Global learning disability, Autism, psychosis, bipolar disorder, depression, suicidal
ideation, or another psychiatric disorder requiring treatment with additional
psychotropic medication, current substance dependance or regular use, and severe
sleep disorders
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02205268      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740